Successful treatment of chronic graft-versus-host disease with sulfasalazine in allogeneic bone marrow transplantation.
Okada
M
M
Second Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan.
Okamoto
T
T
Yamada
S
S
Yamada
S
S
Itoh
T
T
Mori
A
A
Saheki
K
K
Takatsuka
H
H
Wada
H
H
Tamura A
Y
Y
Fujimori
Y
Y
Takemoto
Y
Y
Kakishita
E
E
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000328:Adult; D016026:Bone Marrow Transplantation; D002908:Chronic Disease; D003131:Combined Modality Therapy; D004359:Drug Therapy, Combination; D006086:Graft vs Host Disease / Q000628:therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D011239:Prednisolone / Q000627:therapeutic use; D012460:Sulfasalazine / Q000627:therapeutic use*; D016559:Tacrolimus / Q000627:therapeutic use; D014184:Transplantation, Homologous; D016896:Treatment Outcome
D000276:Adjuvants, Immunologic; D007166:Immunosuppressive Agents; D012460:Sulfasalazine; D011239:Prednisolone; D016559:Tacrolimus